Specialty Medications

Avirax Pharmaceuticals PLC has developed a strong portfolio of patent-protected specialty medicines for global markets. Over the years, we have nurtured and expanded this evolving business through increased focus and strategic investments.

Our key target segments include dermatology, ophthalmology, and oncology — areas where innovation can make a significant difference in patient care. Our primary goal is to improve patient outcomes, either by addressing unmet medical needs or by enhancing patient convenience through differentiated dosage forms.

Our initiatives span the entire value chain, including:

• In-licensing early- to late-stage clinical candidates
• Accessing patented on-market products to strengthen our offerings

Today, Avirax Pharmaceuticals PLC is recognized among the leading branded specialty pharmaceutical companies in the United States, with several specialty products successfully launched and making a meaningful impact.